$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

$jrss Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-K Financial Statement

#000114420416090978 Filed on March 29, 2016

Income Statement

Concept	2016 Q1	2015 Q4	2015
Revenue	$4.409M	$3.810M	$11.87M
YoY Change	81.6%	145.81%	98.55%
Cost Of Revenue	$1.106M	$1.010M	$3.331M
YoY Change	55.84%	129.55%	91.97%
Gross Profit	$3.302M	$2.800M	$8.541M
YoY Change	92.24%	152.25%	101.24%
Gross Profit Margin	74.91%	73.49%	71.94%
Selling, General & Admin	$730.0K	$630.0K	$2.077M
YoY Change	82.5%	50.0%	39.46%
% of Gross Profit	22.1%	22.5%	24.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$240.3K	$240.0K	$871.9K
YoY Change	23.96%	242.86%	397.39%
% of Gross Profit	7.28%	8.57%	10.21%
Operating Expenses	$1.600M	$1.420M	$4.667M
YoY Change	64.95%	125.4%	101.63%
Operating Profit	$1.360M	$1.380M	$2.629M
YoY Change	196.01%	187.5%	186.45%
Interest Expense	$343.8K	-$340.0K	$1.244M
YoY Change	18.9%	-2.86%	23.01%
% of Operating Profit	25.28%	-24.64%	47.32%
Other Income/Expense, Net	$1.269K	$0.00	$9.320K
YoY Change	-87.31%	-100.0%	-63.16%
Pretax Income	$1.361M	$1.040M	$2.639M
YoY Change	188.42%	642.86%	179.75%
Income Tax	$864.00	$0.00	$2.604K
% Of Pretax Income	0.06%	0.0%	0.1%
Net Earnings	$940.3K	$710.0K	$1.791M
YoY Change	190.18%	787.5%	192.84%
Net Earnings / Revenue	21.33%	18.64%	15.08%
Basic Earnings Per Share
Diluted Earnings Per Share	$56.29K	$42.54K	$107.7K
COMMON SHARES
Basic Shares Outstanding	13.92M shares	13.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2015 Q4	2015
SHORT-TERM ASSETS
Cash & Short-Term Investments	$410.0K	$350.0K	$352.2K
YoY Change	-14.58%	-66.67%	-66.35%
Cash & Equivalents	$414.0K	$352.2K	$352.2K
Short-Term Investments
Other Short-Term Assets	$1.390M	$260.0K	$264.6K
YoY Change	25.23%	-66.67%	-66.27%
Inventory	$560.0K	$499.1K	$499.1K
Prepaid Expenses		$201.5K
Receivables	$2.560M	$2.009M	$2.009M
Other Receivables	$1.170M	$2.125K	$1.082M
Total Short-Term Assets	$6.090M	$4.208M	$4.208M
YoY Change	100.95%	47.1%	47.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.42M	$22.45M	$22.45M
YoY Change	6.07%	10.41%	10.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.070M	$1.080M	$1.080M
YoY Change	35.44%	58.82%	59.56%
Total Long-Term Assets	$23.50M	$23.53M	$23.53M
YoY Change	7.19%	11.99%	11.99%
TOTAL ASSETS
Total Short-Term Assets	$6.090M	$4.208M	$4.208M
Total Long-Term Assets	$23.50M	$23.53M	$23.53M
Total Assets	$29.59M	$27.74M	$27.74M
YoY Change	18.58%	16.2%	16.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$480.0K	$352.8K	$352.8K
YoY Change	68.86%	21.19%	21.19%
Accrued Expenses	$50.00K	$40.00K	$44.38K
YoY Change	66.67%	33.33%	44.04%
Deferred Revenue
YoY Change
Short-Term Debt	$520.0K	$0.00	$97.33K
YoY Change	9.75%	-100.0%	-94.5%
Long-Term Debt Due	$1.910M	$1.880M	$1.881M
YoY Change	60.5%	132.1%	132.97%
Total Short-Term Liabilities	$3.000M	$2.461M	$2.461M
YoY Change	21.22%	-17.31%	-17.31%
LONG-TERM LIABILITIES
Long-Term Debt	$17.77M	$17.86M	$17.86M
YoY Change	5.71%	12.33%	12.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$17.77M	$17.86M	$17.86M
YoY Change	5.71%	12.33%	12.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.000M	$2.461M	$2.461M
Total Long-Term Liabilities	$17.77M	$17.86M	$17.86M
Total Liabilities	$24.93M	$20.32M	$24.05M
YoY Change	29.28%	7.66%	9.93%
SHAREHOLDERS EQUITY
Retained Earnings		$2.802M
YoY Change		177.04%
Common Stock		$1.146M
YoY Change		18.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.660M	$3.688M	$3.688M
YoY Change
Total Liabilities & Shareholders Equity	$29.59M	$27.74M	$27.74M
YoY Change	18.58%	16.2%	16.2%

Cashflow Statement

Concept	2016 Q1	2015 Q4	2015
OPERATING ACTIVITIES
Net Income	$940.3K	$710.0K	$1.791M
YoY Change	190.18%	787.5%	192.84%
Depreciation, Depletion And Amortization	$240.3K	$240.0K	$871.9K
YoY Change	23.96%	242.86%	397.39%
Cash From Operating Activities	$1.350M	$1.100M	$2.532M
YoY Change	297.06%	35.8%	23.24%
INVESTING ACTIVITIES
Capital Expenditures	$70.57K	-$1.400M	$5.154M
YoY Change	-91.35%	2.94%	43.43%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$10.00K	$621.1K
YoY Change	-100.0%	-75.0%	854.72%
Cash From Investing Activities	-$1.180M	-$1.390M	-$4.533M
YoY Change	12.38%	5.3%	8.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$178.0K
YoY Change	-100.0%		-80.61%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	350.0K	1.335M
YoY Change	-171.43%	-20.45%	-47.37%
NET CHANGE
Cash From Operating Activities	1.350M	1.100M	2.532M
Cash From Investing Activities	-1.180M	-1.390M	-4.533M
Cash From Financing Activities	-100.0K	350.0K	1.335M
Net Change In Cash	70.00K	60.00K	-665.7K
YoY Change	-112.28%	-185.71%	-261.8%
FREE CASH FLOW
Cash From Operating Activities	$1.350M	$1.100M	$2.532M
Capital Expenditures	$70.57K	-$1.400M	$5.154M
Free Cash Flow	$1.279M	$2.500M	-$2.622M
YoY Change	-369.03%	15.21%	70.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	dei	Trading Symbol TradingSymbol	JRSS
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13915000	shares
CY2015Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	352153	USD
CY2015Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	USD
CY2014Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	92630	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	4207639	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	2860358	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22447911	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20331864	USD
CY2015Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	828131	USD
CY2014Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	677013	USD
CY2015Q4	us-gaap	Assets Assets	27735819	USD
CY2014Q4	us-gaap	Assets Assets	23869235	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	352789	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	291097	USD
CY2015Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2014Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	471277	USD
CY2015Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	6666	USD
CY2014Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	6526	USD
CY2015Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	97328	USD
CY2014Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1300198	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	78307	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	68400	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	44376	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	30808	USD
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1881200	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	807478	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2460666	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2975784	USD
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	17863608	USD
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	15903211	USD
CY2015Q4	us-gaap	Liabilities Liabilities	20324274	USD
CY2014Q4	us-gaap	Liabilities Liabilities	18878995	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	13915	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	13604	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1132423	USD
CY2015	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1046485	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2009469	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	661665	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	499080	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	180630	USD
CY2015Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2125	USD
CY2014Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1755	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	201542	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	691802	USD
CY2015Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1080236	USD
CY2014Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	185391	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2937981	USD
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3041629	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	5979610	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1735300	USD
CY2014	jrss	Cost Of Medical Consumables CostOfMedicalConsumables	451394	USD
CY2014	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1176798	USD
CY2014	us-gaap	Supplies Expense SuppliesExpense	100998	USD
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	35348	USD
CY2014	us-gaap	Utilities Costs UtilitiesCosts	62367	USD
CY2015	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	0	USD
CY2015	us-gaap	Interest Expense InterestExpense	1244185	USD
CY2015	us-gaap	Professional Fees ProfessionalFees	200904	USD
CY2015	us-gaap	Depreciation Depreciation	871948	USD
CY2015	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9242940	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2638784	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2604	USD
CY2015	us-gaap	Profit Loss ProfitLoss	2636180	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	845467	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	1790713	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	118209	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-274714	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2243257	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	727258	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1515999	USD
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13850244	shares
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1440617	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	392318	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	341698	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83033	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-491212	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20982	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	80102	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	216686	USD
CY2015	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-812162	USD
CY2014	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	178700	USD
CY2015	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	501	USD
CY2014	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-2625	USD
CY2015	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	754322	USD
CY2014	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	7003	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5153796	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3593370	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	27220	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	3687853	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	954686	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2802184	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1011471	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-260669	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14045	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	3723692	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	2996434	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7411545	USD
CY2015	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1876362	USD
CY2015	us-gaap	Supplies Expense SuppliesExpense	351353	USD
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	36013	USD
CY2015	us-gaap	Utilities Costs UtilitiesCosts	491209	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1993806	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4990240	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27735819	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23869235	USD
CY2015Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	63034	USD
CY2014Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	0	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20864591	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	532727	USD
CY2014Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2015Q4	us-gaap	Deferred Costs DeferredCosts	252138	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5503971	USD
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	6368432	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	11872403	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3331264	USD
CY2015	jrss	Cost Of Medical Consumables CostOfMedicalConsumables	839702	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	0	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	153568	USD
CY2014	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2651	USD
CY2014	us-gaap	Interest Expense InterestExpense	1011476	USD
CY2014	us-gaap	Professional Fees ProfessionalFees	156444	USD
CY2014	us-gaap	Depreciation Depreciation	175303	USD
CY2014	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5061647	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	917963	USD
CY2015	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	9321	USD
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	25299	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	943262	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2157	USD
CY2014	us-gaap	Profit Loss ProfitLoss	941105	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	329611	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	611494	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	4241	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9814	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	927050	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	325370	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	601680	USD
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.0453
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13494129	shares
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.1293
CY2015	us-gaap	Interest Expense Other InterestExpenseOther	1244185	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	12370	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	15363	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2531639	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2054183	USD
CY2015	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	44952	USD
CY2014	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	65060	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4532655	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4180126	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	178048	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	918290	USD
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2149439	USD
CY2014	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1593231	USD
CY2015	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	4872018	USD
CY2014	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1626490	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1335318	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2537376	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-28634	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	3764	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-694332	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	415197	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	631288	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	2604	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	2157	USD
CY2015	us-gaap	Interest Paid InterestPaid	1244185	USD
CY2014	us-gaap	Interest Paid InterestPaid	1007743	USD
CY2015	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1099730	USD
CY2014	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1114145	USD
CY2015	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	939964	USD
CY2014	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0	USD
CY2012Q4	jrss	Joint Venture Investment Obligation To Pay Capital JointVentureInvestmentObligationToPayCapital	35000000	CNY
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2015Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2035271	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	688885	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25802	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23745925	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1298014	USD
CY2015	jrss	Consulting Fee ConsultingFee	125210	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	1849799	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	1178922	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	14834887	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	19744808	USD
CY2015	jrss	Capital Lease Financing Fees CapitalLeaseFinancingFees	1217539	USD
CY2014	jrss	Capital Lease Financing Fees CapitalLeaseFinancingFees	1007743	USD
CY2015Q4	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.0784	pure
CY2015	us-gaap	Interest Expense Debt InterestExpenseDebt	33967	USD
CY2014	us-gaap	Interest Expense Debt InterestExpenseDebt	1644	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13915000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13604000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13604000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13915000	shares
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	2629463	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3144900	USD
CY2014	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	918290	USD
CY2015	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	178048	USD
CY2015	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-576189	USD
CY2014	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	651816	USD
CY2015	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	465579	USD
CY2014	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-471682	USD
CY2014	us-gaap	Interest Expense Other InterestExpenseOther	1007743	USD
CY2012Q4	jrss	Joint Venture Investment Obligation To Pay Capital JointVentureInvestmentObligationToPayCapital	5555556	USD
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; PADDING-BOTTOM: 0in; BORDER-TOP-COLOR: #000000; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt"> C.</font></i></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 95%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="95%"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt">Use of estimates</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of audited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ from those estimates. Significant items subject to such estimates and assumptions include valuation allowances for receivables and recoverability of carrying amount and the estimated useful lives of long-lived assets. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	0	USD
CY2013Q2	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.7	pure
CY2015	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; PADDING-BOTTOM: 0in; BORDER-TOP-COLOR: #000000; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt"> Q.</font></i></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 95%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="95%"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt"> Reclassification</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The comparative figures have been reclassified to conform to current year presentation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	0	USD
CY2015Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	0	USD
CY2014Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	0	USD
CY2014	jrss	Consulting Fee ConsultingFee	0	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	1881200	USD
CY2013Q2	jrss	Capital Leases Frequency Of Periodic Payment CapitalLeasesFrequencyOfPeriodicPayment	annual
CY2015	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1114018	USD
CY2014	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	601031	USD
CY2015	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2014	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1161940	USD
CY2015Q4	jrss	Construction In Progress ConstructionInProgress		USD
CY2014Q4	jrss	Construction In Progress ConstructionInProgress		USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	269765	USD
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; PADDING-BOTTOM: 0in; BORDER-TOP-COLOR: #000000; PADDING-LEFT: 0in; WIDTH: 3%; PADDING-RIGHT: 0in; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>E.</font></i></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 95%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="95%"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments that potentially subject the Company to concentrations of credit risk are cash, accounts receivable and other receivables arising from its normal business activities. The Company places its cash in what it believes to be credit-worthy financial institutions. The Company has a diversified customer base. The majority of sales are either cash receipt in advance or cash receipt upon delivery. For the years ended December 31, 2015 and 2014, no customer accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of net revenue. As of December 31, 2015and 2014, 1 and 1 customer accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% of net accounts receivable, respectively. For those credit sales, the Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable credit risk exposure beyond such allowance is limited.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-14055	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-392923	USD

Files In Submission

Name	View Source	Status
0001144204-16-090978-index-headers.html	Edgar Link	pending
0001144204-16-090978-index.html	Edgar Link	pending
0001144204-16-090978.txt	Edgar Link	pending
0001144204-16-090978-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
jrss-20151231.xml	Edgar Link	completed
jrss-20151231.xsd	Edgar Link	pending
jrss-20151231_cal.xml	Edgar Link	unprocessable
jrss-20151231_def.xml	Edgar Link	unprocessable
jrss-20151231_lab.xml	Edgar Link	unprocessable
jrss-20151231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpg05.jpg	Edgar Link	pending
v435319_10k.htm	Edgar Link	pending
v435319_ex31-1.htm	Edgar Link	pending
v435319_ex31-2.htm	Edgar Link	pending
v435319_ex32-1.htm	Edgar Link	pending
v435319_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

2016 Q1 Form 10-K Financial Statement

#000114420416090978 Filed on March 29, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS JRSIS HEALTH CARE Corp Stock $jrss

2016 Q1 Form 10-K Financial Statement

#000114420416090978 Filed on March 29, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss